The company's revenue from operations at Rs. 6,235.9 crore increased by 9.4% YoY. 

 The company's US formulations revenue increased by 10.8% YoY to Rs. 2,971.1 crore.

Aurobindo Pharma Ltd posted net profit at Rs. 520.5 crore for the first quarter ended 30 June, 2022 as against Rs. 576.4 Cr in the previous quarter.

The company's revenue from operations at Rs. 6,235.9 crore increased by 9.4% YoY. 
 
The company's US formulations revenue increased by 10.8% YoY to Rs. 2,971.1 crore.

K. Nithyananda Reddy, Vice-Chairman and Managing Director of the Company said, “Our focus on the development of specialty products pipeline will establish new avenues to grow the business in future. This along with our aim to drive sustained improvement in profitability through newer avenues will enhance improved
profitability over medium to long term.”